CALIDI BIOTHERAPEUTICS INC(CLDI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLDI CALIDI BIOTHERAPEUTICS INC

未开盘 04-01 16:00:00 EDT

0.2426

+0.0038

+1.59%

盘后0.2499

+0.0073+3.01%

19:08 EDT

最高0.2496	最低0.2353	成交量16.33万
今开0.2400	昨收0.2388	日振幅5.99%
总市值264.33万	流通市值236.62万	总股本1,090万
成交额3.94万	换手率1.67%	流通股本975.35万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLDI","market":"US","secType":"STK","nameCN":"CALIDI BIOTHERAPEUTICS INC","latestPrice":0.2426,"timestamp":1775073600000,"preClose":0.2388,"halted":0,"volume":163296,"hourTrading":{"tag":"盘后","latestPrice":0.2499,"preClose":0.2426,"latestTime":"19:08 EDT","volume":4930,"amount":1230.8936,"timestamp":1775084901597,"change":0.0073,"changeRate":0.030091,"amplitude":0.035037},"delay":0,"changeRate":0.01591289782244555,"floatShares":9753500,"shares":10895725,"eps":-5.95,"marketStatus":"未开盘","change":0.0038,"latestTime":"04-01 16:00:00 EDT","open":0.24,"high":0.2496,"low":0.2353,"amount":39350.98516608,"amplitude":0.059883,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-5.95,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1775116800000},"marketStatusCode":0,"adr":0,"exchange":"AMEX","adjPreClose":0.2388,"preHourTrading":{"tag":"盘前","latestPrice":0.2401,"preClose":0.2388,"latestTime":"09:17 EDT","volume":37083,"amount":8815.27137756,"timestamp":1775049438023,"change":0.0013,"changeRate":0.005444,"amplitude":0.061558},"postHourTrading":{"tag":"盘后","latestPrice":0.2499,"preClose":0.2426,"latestTime":"19:08 EDT","volume":4930,"amount":1230.8936,"timestamp":1775084901597,"change":0.0073,"changeRate":0.030091,"amplitude":0.035037},"volumeRatio":0.40125},"requestUrl":"/m/hq/s/CLDI/wiki","defaultTab":"wiki","newsList":[{"id":"1109014411","title":"Calidi Biotherapeutics 公布2025年第四季度及全年财务业绩与近期运营亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=1109014411","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109014411?lang=zh_cn&edition=full","pubTime":"2026-03-28 04:26","pubTimestamp":1774643190,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics 发布了2025年第四季度及全年的财务业绩报告，并同步更新了公司近期的运营进展。公司在此期间持续推进其生物治疗技术的研发与应用，展现了在创新疗法领域的持续投入与阶段性成果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131366728","title":"Calidi Biotherapeutics与Avance Clinical达成合作，旨在加速澳大利亚监管审批并推进Cld-401临床试验启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1131366728","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131366728?lang=zh_cn&edition=full","pubTime":"2026-03-24 20:17","pubTimestamp":1774354633,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics（简称CLDI）宣布与Avance Clinical建立合作伙伴关系，双方将共同推进在澳大利亚的监管审批流程，并加速启动Cld-401的临床试验。这一合作有望为Calidi Biotherapeutics的临床开发计划提供重要支持，助力其加快创新疗法的落地进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122220268","title":"Calidi Biotherapeutics完成600万美元承销公开发行 承销商超额配售权获全额行使","url":"https://stock-news.laohu8.com/highlight/detail?id=1122220268","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122220268?lang=zh_cn&edition=full","pubTime":"2026-03-10 08:51","pubTimestamp":1773103909,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics（股票代码：CLDI）宣布已完成600万美元的承销公开发行。此次发行中，承销商全额行使了超额配售选择权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617456724","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘股价大涨6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617456724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617456724?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:56","pubTimestamp":1772636164,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日22时56分，Calidi Biotherapeutics, Inc.股票出现波动，股价大幅拉升6.43%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Can Fite Biopharma Ltd、Scisparc Ltd.、Moolec Science Sa C/Wts 30/01/2028涨幅较大，Can Fite Biopharma Ltd、Klotho Neurosciences, Inc.、Onconetix, Inc.较为活跃，换手率分别为2160.20%、49.83%、34.07%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Can Fite Biopharma Ltd、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为51.24%、41.60%、39.80%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304225604a6a2a4ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304225604a6a2a4ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","BK4139","AAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614511580","title":"Calidi Biotherapeutics, Inc.盘中异动 股价大涨7.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614511580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614511580?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:34","pubTimestamp":1772030064,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日22时34分，Calidi Biotherapeutics, Inc.股票出现异动，股价大幅拉升7.84%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Moolec Science Sa C/Wts 30/01/2028、Surrozen Inc C/Wts 01/08/2031 、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Quince Therapeutics, Inc.、Ensysce Biosciences, Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为157.39%、20.78%、14.14%，振幅较大的相关个股有Larimar Therapeutics, Inc.、Onkure Therapeutics, Inc.、Moolec Science Sa C/Wts 30/01/2028，振幅分别为15.45%、11.37%、10.90%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225223424a71e8e6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225223424a71e8e6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI","AAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600384900","title":"Calidi Biotherapeutics, Inc.盘中异动 股价大涨5.43%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600384900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600384900?lang=zh_cn&edition=full","pubTime":"2026-01-01 02:40","pubTimestamp":1767206449,"startTime":"0","endTime":"0","summary":"北京时间2026年01月01日02时40分，Calidi Biotherapeutics, Inc.股票出现波动，股价大幅拉升5.43%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Vanda Pharmaceuticals Inc.、Axsome Therapeutics, Inc.涨幅较大，Pmgc Holdings Inc.、Gri Bio, Inc.、Dermata Therapeutics, Inc.较为活跃，换手率分别为63.23%、60.66%、52.18%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Moolec Science Sa C/Wts 30/01/2028、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为86.09%、50.00%、46.36%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101024049a48f8705&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101024049a48f8705&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAA","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585157950","title":"Calidi Biotherapeutics, Inc.盘中异动 股价大跌5.21%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585157950","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585157950?lang=zh_cn&edition=full","pubTime":"2025-11-21 01:39","pubTimestamp":1763660374,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日01时39分，Calidi Biotherapeutics, Inc.股票出现波动，股价大幅跳水5.21%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Psyence Biomedical Ltd.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为1030.22%、27.27%、27.11%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Seres Therapeutics, Inc.，振幅分别为53.02%、48.48%、47.15%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121013934a7073798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121013934a7073798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAA","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584991145","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584991145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584991145?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:39","pubTimestamp":1763476745,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时39分，Calidi Biotherapeutics, Inc.股票出现异动，股价大幅下挫5.27%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Olema Pharmaceuticals, Inc.、Can Fite Biopharma Ltd、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为1137.79%、651.95%、270.04%，振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd，振幅分别为57.86%、27.99%、27.62%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223905a70227b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223905a70227b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAA","CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164580199","title":"CALIDI BIOTHERAPEUTICS INC公布2025年第三季度财务结果及近期运营亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=1164580199","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164580199?lang=zh_cn&edition=full","pubTime":"2025-11-14 05:16","pubTimestamp":1763068573,"startTime":"0","endTime":"0","summary":"CALIDI BIOTHERAPEUTICS INC公布2025年第三季度财务结果及近期运营亮点","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189671790","title":"CALIDI BIOTHERAPEUTICS INC - 出售并转让2250万股Nova Cell，交易额为600万美元 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1189671790","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189671790?lang=zh_cn&edition=full","pubTime":"2025-11-01 04:22","pubTimestamp":1761942128,"startTime":"0","endTime":"0","summary":"CALIDI BIOTHERAPEUTICS INC - 出售并转让2250万股Nova Cell，交易额为600万美元 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575050263","title":"Calidi Biotherapeutics, Inc.盘中异动 临近收盘股价大涨5.16%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575050263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575050263?lang=zh_cn&edition=full","pubTime":"2025-10-14 03:33","pubTimestamp":1760384011,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日03时33分，Calidi Biotherapeutics, Inc.股票出现波动，股价快速拉升5.16%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Compugen医疗、天境生物、Nanobiotix涨幅较大，Quoin Pharmaceuticals Ltd、Tvardi Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为127.68%、63.05%、41.56%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为41.90%、36.36%、34.94%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101403333194c711c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101403333194c711c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAA","BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2573299928","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573299928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573299928?lang=zh_cn&edition=full","pubTime":"2025-10-07 22:48","pubTimestamp":1759848522,"startTime":"0","endTime":"0","summary":"北京时间2025年10月07日22时48分，Calidi Biotherapeutics, Inc.股票出现异动，股价大幅上涨5.77%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Spruce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Indaptus Therapeutics, Inc.、Spruce Biosciences, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为268.14%、246.99%、223.80%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Xenetic Biosciences, Inc.、Indaptus Therapeutics, Inc.，振幅分别为52.85%、45.92%、40.44%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251007224842a456329e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251007224842a456329e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAA","BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518227961","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘大幅下挫5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227961?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:00","pubTimestamp":1741615251,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时00分，Calidi Biotherapeutics, Inc.股票出现异动，股价快速跳水5.64%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022005198a2a4be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022005198a2a4be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517049910","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘大幅上涨6.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517049910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517049910?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185035,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Calidi Biotherapeutics, Inc.股票出现波动，股价大幅拉升6.81%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223035963adbed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223035963adbed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516217658","title":"Calidi Biotherapeutics, Inc.盘中异动 股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516217658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516217658?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:53","pubTimestamp":1741017224,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时53分，Calidi Biotherapeutics, Inc.股票出现异动，股价快速下挫5.63%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235344abe64ecc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235344abe64ecc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514861543","title":"Calidi Biotherapeutics, Inc.盘中异动 急速下挫6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514861543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514861543?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:59","pubTimestamp":1740668382,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时59分，Calidi Biotherapeutics, Inc.股票出现异动，股价快速跳水6.15%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272259429632b718&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272259429632b718&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856304","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘急速上涨5.72%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856304?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:35","pubTimestamp":1740580505,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时35分，Calidi Biotherapeutics, Inc.股票出现异动，股价快速拉升5.72%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223505abddedd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223505abddedd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514905930","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘股价大跌5.26%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514905930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514905930?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:39","pubTimestamp":1740494381,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时39分，Calidi Biotherapeutics, Inc.股票出现波动，股价急速下跌5.26%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522394198924e9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522394198924e9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513272240","title":"Calidi Biotherapeutics, Inc.盘中异动 股价大涨5.71%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513272240","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513272240?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:34","pubTimestamp":1740407642,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时34分，Calidi Biotherapeutics, Inc.股票出现波动，股价急速拉升5.71%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223402a2521502&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223402a2521502&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513829734","title":"Calidi Biotherapeutics, Inc.盘中异动 急速下跌5.43%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513829734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513829734?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:10","pubTimestamp":1740154228,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日00时10分，Calidi Biotherapeutics, Inc.股票出现波动，股价大幅下挫5.43%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222001028988df3ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222001028988df3ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.calidibio.com","stockEarnings":[{"period":"1week","weight":-0.1683},{"period":"1month","weight":-0.6898},{"period":"3month","weight":-0.7926},{"period":"6month","weight":-0.8484},{"period":"1year","weight":-0.9637},{"period":"ytd","weight":-0.7926}],"compareEarnings":[{"period":"1week","weight":-0.0024},{"period":"1month","weight":-0.0454},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.0209},{"period":"1year","weight":0.168},{"period":"ytd","weight":-0.0391}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Calidi Biotherapeutics, Inc.在特拉华州注册成立。该公司是一家公开交易的生物技术公司，率先利用其RedTail平台开发靶向疗法，该平台是一种工程化包膜溶瘤病毒，设计用于系统递送至转移部位。其主要候选药物CLD-401将IL-15超激动剂递送至肿瘤微环境，预计于2026年底提交新药临床试验申请。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.185839},{"month":2,"riseRate":0.6,"avgChangeRate":-0.062337},{"month":3,"riseRate":0.4,"avgChangeRate":-0.220856},{"month":4,"riseRate":0.4,"avgChangeRate":-0.156952},{"month":5,"riseRate":0.25,"avgChangeRate":-0.071752},{"month":6,"riseRate":0.75,"avgChangeRate":-0.069766},{"month":7,"riseRate":0.75,"avgChangeRate":0.345315},{"month":8,"riseRate":0.25,"avgChangeRate":-0.291823},{"month":9,"riseRate":0,"avgChangeRate":-0.182897},{"month":10,"riseRate":0.75,"avgChangeRate":-0.07151},{"month":11,"riseRate":0.5,"avgChangeRate":0.188661},{"month":12,"riseRate":0.2,"avgChangeRate":-0.191351}],"exchange":"AMEX","name":"CALIDI BIOTHERAPEUTICS INC","nameEN":"CALIDI BIOTHERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CALIDI BIOTHERAPEUTICS INC(CLDI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CALIDI BIOTHERAPEUTICS INC(CLDI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CALIDI BIOTHERAPEUTICS INC,CLDI,CALIDI BIOTHERAPEUTICS INC股票,CALIDI BIOTHERAPEUTICS INC股票老虎,CALIDI BIOTHERAPEUTICS INC股票老虎国际,CALIDI BIOTHERAPEUTICS INC行情,CALIDI BIOTHERAPEUTICS INC股票行情,CALIDI BIOTHERAPEUTICS INC股价,CALIDI BIOTHERAPEUTICS INC股市,CALIDI BIOTHERAPEUTICS INC股票价格,CALIDI BIOTHERAPEUTICS INC股票交易,CALIDI BIOTHERAPEUTICS INC股票购买,CALIDI BIOTHERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CALIDI BIOTHERAPEUTICS INC(CLDI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CALIDI BIOTHERAPEUTICS INC(CLDI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}